National Research Corporation
General ticker "NRC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $345.4M (TTM average)
National Research Corporation follows the US Stock Market performance with the rate: 33.3%.
Estimated limits based on current volatility of 2.2%: low 20.98$, high 21.92$
Factors to consider:
- Earnings expected soon, date: 2026-01-26 bmo
- Company pays dividends (quarterly): last record date 2025-12-26, amount 0.16$ (Y2.88%)
- Total employees count: 368 (-15.4%) as of 2024
- US accounted for 100.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Loss of major customers, Market competition, Pandemic risks, Vendor dependency, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.84$, 22.63$]
- 2025-12-31 to 2026-12-31 estimated range: [11.15$, 22.66$]
Financial Metrics affecting the NRC estimates:
- Positive: with PPE of 16.7 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 24.60 > 18.33
- Negative: negative Industry operating cash flow (median)
- Negative: 0.01 < Interest expense per share per price, % of 0.63
- Positive: 6.63 < Operating cash flow per share per price, % of 8.34
- Positive: 19.35 < Shareholder equity ratio, % of 23.60 <= 42.53
Short-term NRC quotes
Long-term NRC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $151.57MM | $148.58MM | $143.06MM |
| Operating Expenses | $105.03MM | $108.53MM | $107.87MM |
| Operating Income | $46.54MM | $40.05MM | $35.19MM |
| Non-Operating Income | $-3.73MM | $-0.08MM | $-2.50MM |
| Interest Expense | $1.21MM | $0.86MM | $2.60MM |
| Income(Loss) | $42.81MM | $39.96MM | $32.69MM |
| Taxes | $11.02MM | $8.99MM | $7.91MM |
| Profit(Loss)* | $31.80MM | $30.97MM | $24.78MM |
| Stockholders Equity | $72.03MM | $48.95MM | $31.28MM |
| Assets | $130.46MM | $122.44MM | $132.54MM |
| Operating Cash Flow | $36.27MM | $38.11MM | $34.62MM |
| Capital expenditure | $9.84MM | $15.78MM | $15.45MM |
| Investing Cash Flow | $-9.84MM | $-15.78MM | $-20.28MM |
| Financing Cash Flow | $-55.58MM | $-40.71MM | $-16.76MM |
| Earnings Per Share** | $1.28 | $1.26 | $1.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.